Betting on 2014’s ‘Secret’ Bull Market

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.

It was a mixed week for U.S. stock markets, with the Dow Jones down 0.55%, the S&P 500 flat and the NASDAQ up 0.46%. The MCSI Emerging Markets Index resumed its rally and ended the week 3.17% higher.

Big gainers in your Bull Market Alert portfolio included Tata Motors Limited (TTM), which jumped 5.83% and hit a new 52-week high, on the back of the election of a more business-friendly government of Prime Minister Modi in India. Your holding in Spanish pharma Grifols, S.A. (GRFS) moved back above its 50-day moving average and is now a BUY.

Bull Market Alert is all about identifying bull markets in whatever markets and sectors they may be.

This week’s Bull Market Alert recommendation is the ProShares Ultra Real Estate (URE) exchange-traded fund (ETF) — a 2x leveraged bet on the daily performance of the Dow Jones U.S. Real Estate Index. The Dow Jones U.S. Real Estate Index includes companies that invest directly or indirectly through development, management or ownership of shopping malls, apartment buildings and housing developments, as well as real estate investment trusts (REITs) that invest in apartments, office and retail properties.

The strong performance of U.S. real estate stocks this year just might be the most underreported investment theme of 2014.

U.S. real estate is the single best-performing asset class in my firm Global Guru Capital’s “Ivy Plus” Investment program. With the allocation to U.S. real estate up 16.36% year to date, no other asset class comes close.

All of this comes even as headlines about U.S. real estate aren’t nearly as positive as in the past few years. Scratch the surface, though, and you see that real estate companies are enjoying better cash flow growth as economic data — a reliable long-term indicator of tenant demand — are steadily improving.

I also suspect this year’s strong performance has as much to do with catching up to the rest of the market as anything else. After all, U.S. real estate had a tough 2013, barely eking out a 2.13% gain even as the broader market soared over 30%.

Exclusive  Inflation Might Already be at the Fed’s Target Rate

Today, the entire real estate sector is in a technically bullish phase, even as former high flyers in biotech and healthcare have fallen out of favor.

So buy the ProShares Ultra Real Estate (URE) ETF at market today and place your initial stop at $78.00. If you want to play the options on the real estate theme, I recommend the September $75 calls on the related (but unleveraged) Vanguard REIT Index (VNQ) (VNQ140920C00075000).

Here’s a word of warning. This ProShares Ultra Real Estate ETF generates 2x the return of the index for a single day. Due to the compounding of daily returns, the ETF’s returns over periods other than one day will likely differ from the target return for the same period.

Portfolio Update

The Bank of Ireland (IRE) fell 9.25%. The Bank of Ireland continued its correction last week and touched down to its 200-day moving average (MA). IRE last touched this level back in late June 2013, then proceeded to rise 193% to its February 2014 52-week high. With many of my favorite technical indicators showing IRE as oversold, and IRE’s 200-day MA 103% higher than it was in February 2013, IRE may be nearing a point to repeat this cycle once again. IRE is a HOLD.

AbbVie Inc. (ABBV) added 1.28% last week. ABBV named biotech heavy-hitter Michael Severino M.D. late last week as its new executive vice president of research and development (R&D) and chief scientific officer. Dr. Severino brings considerable experience to ABBV’s ability to innovate. This personnel addition further realizes AbbVie’s pursuit to expand its new-drug pipeline. Trading above its 50-day MA, ABBV is a BUY.

Exclusive  Take a Global View with This ETF

Grifols, S.A. (GRFS) rose 1.53% over the past five trading days. Your bet on the expansion of this Spain-based biotech name rose above the 50-day MA early last week — consistent with an upturn in the broader biotech sector. GRFS is now a BUY.

Tata Motors Limited (TTM) gained 5.83% last week and hit a new 52-week high, as the Indian market soared upon the election of the Bharatiya Janata Party (BJP) and Prime Minister Modi. Tata Motors itself announced that it was hiring more than 3,000 sales staff in India to support two large new product launches. TTM will soon begin selling its highly anticipated new compact sedan named Zest and hatchback named Bolt. TTM is a BUY.

iShares MSCI Philippines (EPHE) moved 1.41% higher during its first week in your Bull Market Alert portfolio. The Philippines’ market is on a firm path higher since forming a compelling bottom at the $29 price level. With last year’s $43.50 all-time May high set as a potential target in the coming months, EPHE has plenty of room to recover. EPHE is a BUY.

NOTE: Global Guru Capital is a Securities and Exchange Commission-registered investment adviser, and is not affiliated with Eagle Financial Publications.

Nicholas Vardy

share on:

Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE

share on:


Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

  • Forecasts & Strategies
  • Home Run Trader
  • Fast Money Alert
  • Five Star Trader
  • TNT Trader

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

  • Cash Machine
  • Premium Income PRO (exclusively for subscribers of Cash Machine)
  • Quick Income Trader
  • Breakout Options Alert
  • Hi-Tech Trader

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

  • Successful Investing
  • High Velocity Options
  • Intelligence Report
  • Bullseye Stock Trader
  • Eagle Eye Opener

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

  • Retirement Watch
  • Retirement Watch Spotlight Series
  • Lifetime Retirement Protection Program

Jon Johnson

Jon Johnson's philosophy in investing and trading is to take what the market gives you regardless if that is to the upside or downside. For the past 21 years, Jon has helped thousands of clients gain success in the financial markets through his newsletters and education services:

Product Details

  • Investment House Daily
  • Stock of the Week
  • Technical Traders Alert
  • Rapid Profits Stock Trader

Used by financial advisors and individual investors all over the world, is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

  • Dividend Investor